and/or

912 Blog posts found

Announcement

News from #AACR16: Precision Medicine Progress, Turbocharged CARs, and Turning Up the Heat against Cancer

At the 2016 American Association for Cancer Research (AACR) conference, there were clear signs that cancer treatment is evolving from a slash-and-burn method to a more precisely targeted, intelligent approach.

José Baselga

Announcement

News from #AACR16: Targeted Therapy Breakthrough, Improved Survival in Melanoma, and Benefits of Gut Bugs

Long-awaited results of clinical trials testing targeted drugs and immunotherapy combinations were on offer at the annual American Association for Cancer Research (AACR) conference.

Dr. Joan Massagué, Sloan Kettering Institute Director received the Pezcoller Foundation-AACR International Award for Cancer Research and was named an AACR fellow at AACR16.

Announcement

MSK Is Named Founding Member of Parker Institute for Cancer Immunotherapy

Cancer immunotherapy got a big boost today in the form of a $250 million grant from the Parker Foundation and a new brain trust composed of the world’s top scientists.

Sean Parker

Feature

Ready to Fight, but My Doctor Says to Wait: Watchful Waiting after a Lymphoma Diagnosis

The watch and wait approach to treatment, also called active surveillance, is common for lymphomas that pose no immediate threat to a patient’s health. But the tactic can leave some patients initially feeling anxious.

Woman diagnosed with lymphoma

In the Clinic

Driving Armored CARs at Cancer

Hundreds of scientists from around the world gathered at MSK last month for a symposium devoted to a promising new immunotherapy approach called CAR T cell therapy.

In the Lab

Surprising Discovery Connects Rare Vascular Disease to Cancer Gene

Researchers found that a common cancer gene called PIK3CA also causes the condition venous malformation. Their discovery has already pointed the way to targeted therapies for this rare and painful condition that affects one in 10,000 people.

scan of mouse blood vessel

In the Lab

Stealth Mode: How Metastatic Cancer Cells Evade Detection by the Immune System

Cancer cells have a sneaky ability to hide out in the body for years at a time. MSK scientists are looking for ways to flush them out.

a sneaky man on a sneaky mission

Announcement

Cancer Patients Find Support through MSK's Teen and Young Adult Program

At any given time, close to 700 teenagers and young adults are in active treatment at Memorial Sloan Kettering. On March 18, MSK opened a hip new space dubbed the Lounge as part of the newly launched Teen and Young Adult Program designed to give these young patients the support they need during a turbulent time.

In the Lab

New Lung Cancer Therapy May Target Previously Untreatable Tumors

Researchers are developing uses for a drug that could benefit many people with lung cancer.

Colored x-ray of lung cancer

In the Lab

Rapid Results: MSK Researchers Link Genetic Mutation to Rare Bladder Cancer

MSK researchers have identified a genetic mutation that plays a central role in a rare, aggressive form of bladder cancer called plasmacytoid variant carcinoma.

David Solit